Membrane vesicles nanotheranostic systems: sources, engineering methods, and challenges

Biomed Mater. 2021 Feb 24;16(2):022009. doi: 10.1088/1748-605X/abd2c8.

Abstract

Extracellular vesicles (EVs) are cell secretory native components with long-circulation, good biocompatibility, and physiologic barriers cross ability. EVs derived from different donor cells inherit varying characteristics and functions from their original cells and are favorable to serve as vectors for diagnosing and treating various diseases. However, EVs nanotheranostics are still in their infancy because of their limited accumulation at lesion sites and compromised therapy efficiency. Hence, engineering modification of EVs is usually needed to further enhance their stability, biological activity, and lesion-targeting capacity. Herein, we overview the characteristics of EVs from different sources, as well as the latest developments of surface engineering and cargo loading methods. We also focus especially on advances in EVs-based disease theranostics. At the end of the review, we predict the obstacles and prospects of the future clinical application of EVs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Communication*
  • Dendritic Cells / cytology
  • Drug Delivery Systems*
  • Extracellular Vesicles / metabolism
  • Humans
  • Killer Cells, Natural / metabolism
  • Macrophages / metabolism
  • Nanomedicine / methods*
  • Precision Medicine
  • Stem Cells / cytology
  • T-Lymphocytes / metabolism
  • Theranostic Nanomedicine / instrumentation
  • Theranostic Nanomedicine / methods*
  • Tissue Engineering / instrumentation
  • Tissue Engineering / methods*